Quality improvement in neurology: Amyotrophic Lateral Sclerosis Quality Measures

Robert G. Miller; Benjamin Rix Brooks; Rebecca J. Swain-Eng; Robert C. Basner; Gregory T. Carter; Patricia Casey; Adam B. Cohen; Richard Dubinsky; Dallas Forshew; Carlayne E. Jackson; Ed Kasarskis; Nicholas J. Procaccini; Mohammed Sanjak; Fredrik P. Tolin

doi:10.3109/21678421.2013.875706

Quality improvement in neurology: Amyotrophic Lateral Sclerosis Quality Measures

Robert G. Miller, Benjamin Rix Brooks, Rebecca J. Swain-Eng, Robert C. Basner, Gregory T. Carter, Patricia Casey, Adam B. Cohen, Richard Dubinsky, Dallas Forshew, Carlayne E. Jackson, Ed Kasarskis, Nicholas J. Procaccini, Mohammed Sanjak, Fredrik P. Tolin

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Original language	English (US)
Pages (from-to)	165-168
Number of pages	4
Journal	Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Volume	15
Issue number	3-4
DOIs	https://doi.org/10.3109/21678421.2013.875706
State	Published - Jun 2014

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.3109/21678421.2013.875706

Cite this

Miller, R. G., Brooks, B. R., Swain-Eng, R. J., Basner, R. C., Carter, G. T., Casey, P., Cohen, A. B., Dubinsky, R., Forshew, D., Jackson, C. E., Kasarskis, E., Procaccini, N. J., Sanjak, M., & Tolin, F. P. (2014). Quality improvement in neurology: Amyotrophic Lateral Sclerosis Quality Measures. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 15(3-4), 165-168. https://doi.org/10.3109/21678421.2013.875706

Miller, RG, Brooks, BR, Swain-Eng, RJ, Basner, RC, Carter, GT, Casey, P, Cohen, AB, Dubinsky, R, Forshew, D, Jackson, CE, Kasarskis, E, Procaccini, NJ, Sanjak, M & Tolin, FP 2014, 'Quality improvement in neurology: Amyotrophic Lateral Sclerosis Quality Measures', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 15, no. 3-4, pp. 165-168. https://doi.org/10.3109/21678421.2013.875706

@article{5b486da88fcb495bb0ffa445e9906375,

title = "Quality improvement in neurology: Amyotrophic Lateral Sclerosis Quality Measures",

author = "Miller, {Robert G.} and Brooks, {Benjamin Rix} and Swain-Eng, {Rebecca J.} and Basner, {Robert C.} and Carter, {Gregory T.} and Patricia Casey and Cohen, {Adam B.} and Richard Dubinsky and Dallas Forshew and Jackson, {Carlayne E.} and Ed Kasarskis and Procaccini, {Nicholas J.} and Mohammed Sanjak and Tolin, {Fredrik P.}",

note = "Funding Information: Dr. Miller has received research support from the Muscular Dystrophy, and is a consultant for Cytokinetics, Neuraltus, and Asubio pharmaceuticals. Dr. Brooks has received funding and/or research grants from AB Science, Acorda, ALS Therapy Alliance, Asubio, Avanir., Biogen Idec, Bristol-Myers Squibb, Cytokinetics, GlaxoSmithKline, Knopp Bioscience, Muscular Dystrophy Association, Neu-raltus, NINDS Clinical Research Consortium, QuestCor, and Teva. Ms. Swain-Eng is a full-time employee of the American Academy of Neurology. Dr. Basner is Principal Investigator of a Muscular Dystrophy Association grant,Opto-Electronic Plethysmography (OEP): A novel non-invasive quantitative assessment of lower rib cage paradox and use of accessory muscles in patients with amyotrophic lateral sclerosis; Site Investigator and Sleep Protocol Subcommittee member of an NHLBI/NIH grant, Sleep-Disordered Breathing During Pregnancy and Risks to Cardiovascular Health; and co-investigator of the following: R01HL103676-01A1 NIH/NHLBI; Subclinical Interstitial Lung Disease in MESA; R01HL093081 NIH/NHLBI; Pulmonary Vascular Changes in Early COPD; and InterMune PIPF-016: a randomized, double-blind, placebo-controlled, phase 3 study of the efficacy and safety of Pirfenidone in patients with Idiopathic Pulmonary Fibrosis (IPF). Dr. Carter reports no disclosures. Ms. Casey is a full-time employee of Northwestern Medical Faculty Foundation, Department of Neurology. Dr. Cohen reports no disclosures. Dr. Dubinsky reports disclosures for relationships with Allergan Pharmaceuticals, NIH, and AHRQ. Ms. Forshew is a consultant for Questcor and Asubio Pharmaceuticals. Dr. Jackson has received research support from Knopp Pharmaceuticals, Biogen Idec, and Cytoki-netics. Dr. Kasarskis is a consultant for Asubio Pharmaceuticals and ATSDR. Dr. Procaccini reports no disclosures. Dr. Sanjak reports no disclosures. Dr. Tolin reports no disclosures.",

year = "2014",

month = jun,

doi = "10.3109/21678421.2013.875706",

language = "English (US)",

volume = "15",

pages = "165--168",

journal = "Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders",

issn = "2167-8421",

publisher = "Informa Healthcare",

number = "3-4",

}

TY - JOUR

T1 - Quality improvement in neurology

T2 - Amyotrophic Lateral Sclerosis Quality Measures

AU - Miller, Robert G.

AU - Brooks, Benjamin Rix

AU - Swain-Eng, Rebecca J.

AU - Basner, Robert C.

AU - Carter, Gregory T.

AU - Casey, Patricia

AU - Cohen, Adam B.

AU - Dubinsky, Richard

AU - Forshew, Dallas

AU - Jackson, Carlayne E.

AU - Kasarskis, Ed

AU - Procaccini, Nicholas J.

AU - Sanjak, Mohammed

AU - Tolin, Fredrik P.

N1 - Funding Information: Dr. Miller has received research support from the Muscular Dystrophy, and is a consultant for Cytokinetics, Neuraltus, and Asubio pharmaceuticals. Dr. Brooks has received funding and/or research grants from AB Science, Acorda, ALS Therapy Alliance, Asubio, Avanir., Biogen Idec, Bristol-Myers Squibb, Cytokinetics, GlaxoSmithKline, Knopp Bioscience, Muscular Dystrophy Association, Neu-raltus, NINDS Clinical Research Consortium, QuestCor, and Teva. Ms. Swain-Eng is a full-time employee of the American Academy of Neurology. Dr. Basner is Principal Investigator of a Muscular Dystrophy Association grant,Opto-Electronic Plethysmography (OEP): A novel non-invasive quantitative assessment of lower rib cage paradox and use of accessory muscles in patients with amyotrophic lateral sclerosis; Site Investigator and Sleep Protocol Subcommittee member of an NHLBI/NIH grant, Sleep-Disordered Breathing During Pregnancy and Risks to Cardiovascular Health; and co-investigator of the following: R01HL103676-01A1 NIH/NHLBI; Subclinical Interstitial Lung Disease in MESA; R01HL093081 NIH/NHLBI; Pulmonary Vascular Changes in Early COPD; and InterMune PIPF-016: a randomized, double-blind, placebo-controlled, phase 3 study of the efficacy and safety of Pirfenidone in patients with Idiopathic Pulmonary Fibrosis (IPF). Dr. Carter reports no disclosures. Ms. Casey is a full-time employee of Northwestern Medical Faculty Foundation, Department of Neurology. Dr. Cohen reports no disclosures. Dr. Dubinsky reports disclosures for relationships with Allergan Pharmaceuticals, NIH, and AHRQ. Ms. Forshew is a consultant for Questcor and Asubio Pharmaceuticals. Dr. Jackson has received research support from Knopp Pharmaceuticals, Biogen Idec, and Cytoki-netics. Dr. Kasarskis is a consultant for Asubio Pharmaceuticals and ATSDR. Dr. Procaccini reports no disclosures. Dr. Sanjak reports no disclosures. Dr. Tolin reports no disclosures.

PY - 2014/6

Y1 - 2014/6

UR - http://www.scopus.com/inward/record.url?scp=84901501437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901501437&partnerID=8YFLogxK

U2 - 10.3109/21678421.2013.875706

DO - 10.3109/21678421.2013.875706

M3 - Review article

C2 - 24707820

AN - SCOPUS:84901501437

VL - 15

SP - 165

EP - 168

JO - Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

JF - Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

SN - 2167-8421

IS - 3-4

ER -

Quality improvement in neurology: Amyotrophic Lateral Sclerosis Quality Measures

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this